The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II open-label, multi-centre study of bemcentinib (BGB324), a first-in-class selective AXL inhibitor, in combination with pembrolizumab in patients with advanced NSCLC.
 
James Lorens
Employment - BerGenBio
Leadership - BerGenBio
Stock and Other Ownership Interests - BerGenBio
Research Funding - BerGenBio (Inst)
Patents, Royalties, Other Intellectual Property - BerGenBio
Travel, Accommodations, Expenses - BerGenBio
 
Carlos Eduardo Arce-Lara
No Relationships to Disclose
 
Edurne Arriola
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb
 
Paal Brunsvig
No Relationships to Disclose
 
Enric Carcereny Costa
No Relationships to Disclose
 
Manuel Domine
No Relationships to Disclose
 
Konstantin H. Dragnev
No Relationships to Disclose
 
Enriqueta Felip
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Guardant Health; Lilly; MSD; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer; Roche
 
Rosario Garcia Campelo
No Relationships to Disclose
 
Matthew Krebs
Honoraria - Roche
Consulting or Advisory Role - Achilles Therapeutics; Octimet; Roche
Travel, Accommodations, Expenses - AstraZeneca
 
Santiago Ponce Aix
No Relationships to Disclose
 
James F. Spicer
Stock and Other Ownership Interests - IGEA
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst)
 
Jose Manuel Trigo Perez
No Relationships to Disclose
 
Nuria Vinolas
No Relationships to Disclose
 
Robert J Holt
Employment - BerGenBio
Patents, Royalties, Other Intellectual Property - BerGenBio
 
Anthony Brown
Employment - BerGenBio
Stock and Other Ownership Interests - BerGenBio
 
Michael Jon Chisamore
Employment - Merck Sharp & Dohme